These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 28430916)
1. Osteoclasts Control Lipid Secretion to Regulate Breast Cancer Bone Metastasis. Delgado-Calle J Endocrinology; 2017 Mar; 158(3):458-460. PubMed ID: 28430916 [No Abstract] [Full Text] [Related]
2. Bone resorption and bone metastasis risk. Mathis KM; Sturgeon KM; Winkels RM; Wiskemann J; De Souza MJ; Schmitz KH Med Hypotheses; 2018 Sep; 118():36-41. PubMed ID: 30037612 [TBL] [Abstract][Full Text] [Related]
3. Direct resorption of bone by human breast cancer cells in vitro. Eilon G; Mundy GR Nature; 1978 Dec; 276(5689):726-8. PubMed ID: 732878 [No Abstract] [Full Text] [Related]
4. Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts. Grano M; Mori G; Minielli V; Cantatore FP; Colucci S; Zallone AZ Biochem Biophys Res Commun; 2000 Apr; 270(3):1097-100. PubMed ID: 10772956 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption. Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer-derived factors facilitate osteolytic bone metastasis. Rose AA; Siegel PM Bull Cancer; 2006 Sep; 93(9):931-43. PubMed ID: 16980236 [TBL] [Abstract][Full Text] [Related]
7. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709 [TBL] [Abstract][Full Text] [Related]
8. Metastatic breast cancer induces an osteoblast inflammatory response. Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581 [TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease. Dedes PG; Kanakis I; Gialeli Ch; Theocharis AD; Tsegenidis T; Kletsas D; Tzanakakis GN; Karamanos NK Biochim Biophys Acta; 2013 Jun; 1830(6):3625-34. PubMed ID: 23395844 [TBL] [Abstract][Full Text] [Related]
11. Lipid Osteoclastokines Regulate Breast Cancer Bone Metastasis. Krzeszinski JY; Schwaid AG; Cheng WY; Jin Z; Gallegos ZR; Saghatelian A; Wan Y Endocrinology; 2017 Mar; 158(3):477-489. PubMed ID: 27967239 [TBL] [Abstract][Full Text] [Related]
12. Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption. Zhao YP; Ye WL; Liu DZ; Cui H; Cheng Y; Liu M; Zhang BL; Mei QB; Zhou SY Nanoscale; 2017 May; 9(19):6264-6277. PubMed ID: 28470315 [TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of roasted licorice extract on human metastatic breast cancer cell-induced bone destruction. Lee SK; Park KK; Park JH; Lim SS; Chung WY Phytother Res; 2013 Dec; 27(12):1776-83. PubMed ID: 23401151 [TBL] [Abstract][Full Text] [Related]
14. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Pollari S; Käkönen SM; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O Breast Cancer Res Treat; 2011 Jan; 125(2):421-30. PubMed ID: 20352489 [TBL] [Abstract][Full Text] [Related]
15. [Bone metastases of breast cancer]. Hata K; Yoneda T Clin Calcium; 2014 Aug; 24(8):1177-84. PubMed ID: 25065869 [TBL] [Abstract][Full Text] [Related]
16. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption. Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728 [TBL] [Abstract][Full Text] [Related]
17. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice. Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960 [TBL] [Abstract][Full Text] [Related]
18. Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis. Park HR; Min SK; Cho HD; Kim DH; Shin HS; Park YE J Korean Med Sci; 2003 Aug; 18(4):541-6. PubMed ID: 12923331 [TBL] [Abstract][Full Text] [Related]
19. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer. Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724 [TBL] [Abstract][Full Text] [Related]
20. BONE METASTASES IN ADVANCED BREAST CANCER: RADIOLOGICAL APPEARANCES FOLLOWING HYPOPHYSECTOMY. OWEN J; COLE Y Clin Radiol; 1965 Jul; 16():295-301. PubMed ID: 14324894 [No Abstract] [Full Text] [Related] [Next] [New Search]